浙江亚太药业

Zhejiang Yatai Pharmaceutical is a leading Chinese pharmaceutical enterprise focused on the development, manufacturing, and commercialization of chemical drug products. The company's extensive portfolio includes anti-infectives, cardiovascular agents, and gastrointestinal medications, with a strong emphasis on antibiotics and proton pump inhibitors. Based in Shaoxing, Zhejiang, the company operates high-standard GMP manufacturing lines for various dosage forms, including tablets, capsules, and injections. As a public company listed on the Shenzhen Stock Exchange, it serves both domestic and international markets with a commitment to providing high-quality generic medicines. The firm maintains a dedicated research institute to support its product pipeline and ensure compliance with evolving regulatory standards. Its core business strategy revolves around the mass production of essential medicines to address widespread healthcare needs in China.